Options volume is more than double the daily average, with 81k contracts traded and calls leading puts for a put/call ratio of 0.07, compared to a typical level near 0.54. Implied volatility (IV30) dropped 0.58 to 73.47,above the median, suggesting an expected daily move of $1.13. Put-call skew steepened, indicating increased demand for downside protection.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Prasad appointment not necessarily bad news for biopharma, says Citi
- SPY ETF News, 5/7/2025
- Controversial doctor Vinay Prasad named CBER director, STAT reports
- Cautious Outlook for Moderna Amid Cost Containment and Revenue Uncertainties
- Moderna’s Financial Outlook: Sell Rating Amid Challenging Vaccine Environment and Cost Reductions